Schulten Andre, Chief Financial Officer of Procter & Gamble (PG), has demonstrated a clear selling bias in recent insider transactions, with $2.73 million in total sales compared to just $25,587 in buys across 26 filings. All activity has been concentrated in PG, with no trades in other companies. The most significant disposals occurred on August 19, 2025 ($1.83 million) and October 2, 2025 ($647,289), followed by a cluster of smaller sales on December 3, 2025, including transactions valued at $103,282, $12,794 (twice), and $9,887 (twice). These December transactions were coded as both open market sales (code S) and transactions under Rule 10b5-1 plans (code M), indicating prearranged trading arrangements for some dispositions.
Notably, Andre’s recent activity shows no buying, with the last purchase occurring outside the reported period. The pattern is underscored by multiple awards (code A) with zero reported value, likely representing equity grants or option awards that haven’t been exercised. The absence of buys and the consistency of sales—particularly the two major disposals in August and October—suggest a sustained reduction in exposure to PG shares. The December sales, while smaller in scale, reinforce this directional trend, with all recent transactions flowing in one direction. The use of 10b5-1 plans for some sales indicates these transactions were planned in advance, though the overall disposition pattern remains unambiguous.
AI-assisted summary